Correction: 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis

A Correction to this paper has been published: https://doi.org/10.1038/s41401-021-00670-z

Saved in:
Bibliographic Details
Published in:Acta pharmacologica Sinica 2022-02, Vol.43 (2), p.504-504
Main Authors: Liao, Ya-jin, Pan, Rui-yuan, Kong, Xiang-xi, Cheng, Yong, Du, Lu, Wang, Zhen-chao, Yuan, Chao, Cheng, Jin-bo, Yuan, Zeng-qiang, Zhang, Hai-yan
Format: Article
Language:English
Subjects:
Biomedical and Life Sciences
Biomedicine
Correction
Immunology
Internal Medicine
Medical Microbiology
Pharmacology/Toxicology
Vaccine
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c319z-62de2a42cb81530f86868c4d02146adfe30c0eb444422bf5b4c453dc386049253
cites
container_end_page 504
container_issue 2
container_start_page 504
container_title Acta pharmacologica Sinica
container_volume 43
creator Liao, Ya-jin
Pan, Rui-yuan
Kong, Xiang-xi
Cheng, Yong
Du, Lu
Wang, Zhen-chao
Yuan, Chao
Cheng, Jin-bo
Yuan, Zeng-qiang
Zhang, Hai-yan
description A Correction to this paper has been published: https://doi.org/10.1038/s41401-021-00670-z
doi_str_mv 10.1038/s41401-021-00670-z
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8792055</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622859079</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319z-62de2a42cb81530f86868c4d02146adfe30c0eb444422bf5b4c453dc386049253</originalsourceid><addsrcrecordid>eNp9kVtrHCEUxyW0JGnSL9CHIvQ103qdSx4KZeklsDQlpM_iOGeyhhndqBOy-yX6let0c-tLFFE5__M7fz0IvaPkIyW8_hQFFYQWhOVFyooU2z10SCshi4pJ8Sqfy4oWgtT8AL2J8ZoQzjht9tEB57UkrGoO0Z-FDwFMst6dYnrCTkRxGewIaeXvNi24LTjAEYZZcgvDBlu3sq1NEf9cXvzi-doPehx19CNgPYv0zMLadVinBG7SCSKGuzXMWJf0gPWUvB3HKZPBGViv9ODHDQw22XiMXvd6iPD2fj9Cv799vVz8KJbn388WX5aFyS_YFiXrgGnBTFtTyUlfl3ka0eW_EKXueuDEEGhFHoy1vWyFEZJ3htclEQ2T_Ah93nHXUztCZ7KzoAe1ziZ12Civrfo_4uxKXflbVVcNI3IGfLgHBH8zQUzq2k_BZc-KlYzVsiFVk1VspzLBxxigf6xAiZqbqHZNVNm4-tdEtc1J7597e0x56FoW8J0g5pC7gvBU-wXsX9jgrJs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622859079</pqid></control><display><type>article</type><title>Correction: 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis</title><source>Springer Nature</source><source>PubMed Central</source><creator>Liao, Ya-jin ; Pan, Rui-yuan ; Kong, Xiang-xi ; Cheng, Yong ; Du, Lu ; Wang, Zhen-chao ; Yuan, Chao ; Cheng, Jin-bo ; Yuan, Zeng-qiang ; Zhang, Hai-yan</creator><creatorcontrib>Liao, Ya-jin ; Pan, Rui-yuan ; Kong, Xiang-xi ; Cheng, Yong ; Du, Lu ; Wang, Zhen-chao ; Yuan, Chao ; Cheng, Jin-bo ; Yuan, Zeng-qiang ; Zhang, Hai-yan</creatorcontrib><description>A Correction to this paper has been published: https://doi.org/10.1038/s41401-021-00670-z</description><identifier>ISSN: 1671-4083</identifier><identifier>EISSN: 1745-7254</identifier><identifier>DOI: 10.1038/s41401-021-00670-z</identifier><identifier>PMID: 33850279</identifier><language>eng</language><publisher>Singapore: Springer Singapore</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Correction ; Immunology ; Internal Medicine ; Medical Microbiology ; Pharmacology/Toxicology ; Vaccine</subject><ispartof>Acta pharmacologica Sinica, 2022-02, Vol.43 (2), p.504-504</ispartof><rights>The Author(s), under exclusive licence to CPS and SIMM 2021</rights><rights>The Author(s), under exclusive licence to CPS and SIMM 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319z-62de2a42cb81530f86868c4d02146adfe30c0eb444422bf5b4c453dc386049253</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792055/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792055/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33850279$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liao, Ya-jin</creatorcontrib><creatorcontrib>Pan, Rui-yuan</creatorcontrib><creatorcontrib>Kong, Xiang-xi</creatorcontrib><creatorcontrib>Cheng, Yong</creatorcontrib><creatorcontrib>Du, Lu</creatorcontrib><creatorcontrib>Wang, Zhen-chao</creatorcontrib><creatorcontrib>Yuan, Chao</creatorcontrib><creatorcontrib>Cheng, Jin-bo</creatorcontrib><creatorcontrib>Yuan, Zeng-qiang</creatorcontrib><creatorcontrib>Zhang, Hai-yan</creatorcontrib><title>Correction: 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis</title><title>Acta pharmacologica Sinica</title><addtitle>Acta Pharmacol Sin</addtitle><addtitle>Acta Pharmacol Sin</addtitle><description>A Correction to this paper has been published: https://doi.org/10.1038/s41401-021-00670-z</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Correction</subject><subject>Immunology</subject><subject>Internal Medicine</subject><subject>Medical Microbiology</subject><subject>Pharmacology/Toxicology</subject><subject>Vaccine</subject><issn>1671-4083</issn><issn>1745-7254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kVtrHCEUxyW0JGnSL9CHIvQ103qdSx4KZeklsDQlpM_iOGeyhhndqBOy-yX6let0c-tLFFE5__M7fz0IvaPkIyW8_hQFFYQWhOVFyooU2z10SCshi4pJ8Sqfy4oWgtT8AL2J8ZoQzjht9tEB57UkrGoO0Z-FDwFMst6dYnrCTkRxGewIaeXvNi24LTjAEYZZcgvDBlu3sq1NEf9cXvzi-doPehx19CNgPYv0zMLadVinBG7SCSKGuzXMWJf0gPWUvB3HKZPBGViv9ODHDQw22XiMXvd6iPD2fj9Cv799vVz8KJbn388WX5aFyS_YFiXrgGnBTFtTyUlfl3ka0eW_EKXueuDEEGhFHoy1vWyFEZJ3htclEQ2T_Ah93nHXUztCZ7KzoAe1ziZ12Civrfo_4uxKXflbVVcNI3IGfLgHBH8zQUzq2k_BZc-KlYzVsiFVk1VspzLBxxigf6xAiZqbqHZNVNm4-tdEtc1J7597e0x56FoW8J0g5pC7gvBU-wXsX9jgrJs</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Liao, Ya-jin</creator><creator>Pan, Rui-yuan</creator><creator>Kong, Xiang-xi</creator><creator>Cheng, Yong</creator><creator>Du, Lu</creator><creator>Wang, Zhen-chao</creator><creator>Yuan, Chao</creator><creator>Cheng, Jin-bo</creator><creator>Yuan, Zeng-qiang</creator><creator>Zhang, Hai-yan</creator><general>Springer Singapore</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7QR</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope></search><sort><creationdate>202202</creationdate><title>Correction: 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis</title><author>Liao, Ya-jin ; Pan, Rui-yuan ; Kong, Xiang-xi ; Cheng, Yong ; Du, Lu ; Wang, Zhen-chao ; Yuan, Chao ; Cheng, Jin-bo ; Yuan, Zeng-qiang ; Zhang, Hai-yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319z-62de2a42cb81530f86868c4d02146adfe30c0eb444422bf5b4c453dc386049253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Correction</topic><topic>Immunology</topic><topic>Internal Medicine</topic><topic>Medical Microbiology</topic><topic>Pharmacology/Toxicology</topic><topic>Vaccine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liao, Ya-jin</creatorcontrib><creatorcontrib>Pan, Rui-yuan</creatorcontrib><creatorcontrib>Kong, Xiang-xi</creatorcontrib><creatorcontrib>Cheng, Yong</creatorcontrib><creatorcontrib>Du, Lu</creatorcontrib><creatorcontrib>Wang, Zhen-chao</creatorcontrib><creatorcontrib>Yuan, Chao</creatorcontrib><creatorcontrib>Cheng, Jin-bo</creatorcontrib><creatorcontrib>Yuan, Zeng-qiang</creatorcontrib><creatorcontrib>Zhang, Hai-yan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Acta pharmacologica Sinica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liao, Ya-jin</au><au>Pan, Rui-yuan</au><au>Kong, Xiang-xi</au><au>Cheng, Yong</au><au>Du, Lu</au><au>Wang, Zhen-chao</au><au>Yuan, Chao</au><au>Cheng, Jin-bo</au><au>Yuan, Zeng-qiang</au><au>Zhang, Hai-yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis</atitle><jtitle>Acta pharmacologica Sinica</jtitle><stitle>Acta Pharmacol Sin</stitle><addtitle>Acta Pharmacol Sin</addtitle><date>2022-02</date><risdate>2022</risdate><volume>43</volume><issue>2</issue><spage>504</spage><epage>504</epage><pages>504-504</pages><issn>1671-4083</issn><eissn>1745-7254</eissn><abstract>A Correction to this paper has been published: https://doi.org/10.1038/s41401-021-00670-z</abstract><cop>Singapore</cop><pub>Springer Singapore</pub><pmid>33850279</pmid><doi>10.1038/s41401-021-00670-z</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1671-4083
ispartof Acta pharmacologica Sinica, 2022-02, Vol.43 (2), p.504-504
issn 1671-4083
1745-7254
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8792055
source Springer Nature; PubMed Central
subjects Biomedical and Life Sciences
Biomedicine
Correction
Immunology
Internal Medicine
Medical Microbiology
Pharmacology/Toxicology
Vaccine
title Correction: 1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T21%3A13%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%201,2,4-Trimethoxybenzene%20selectively%20inhibits%20NLRP3%20inflammasome%20activation%20and%20attenuates%20experimental%20autoimmune%20encephalomyelitis&rft.jtitle=Acta%20pharmacologica%20Sinica&rft.au=Liao,%20Ya-jin&rft.date=2022-02&rft.volume=43&rft.issue=2&rft.spage=504&rft.epage=504&rft.pages=504-504&rft.issn=1671-4083&rft.eissn=1745-7254&rft_id=info:doi/10.1038/s41401-021-00670-z&rft_dat=%3Cproquest_pubme%3E2622859079%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c319z-62de2a42cb81530f86868c4d02146adfe30c0eb444422bf5b4c453dc386049253%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2622859079&rft_id=info:pmid/33850279&rfr_iscdi=true